Geoffrey Beran Rose - Aug 16, 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role: Chief Commercial Officer
Signature: /s/ Lauren Cristina, Attorney-in-Fact for Geoffrey Beran Rose
Stock symbol: LUNG
Transactions as of: Aug 16, 2021
Transactions value $: -$256,970
Form type: 4
Date filed: 8/18/2021, 08:09 PM
Previous filing: Jul 19, 2021
Next filing: Sep 3, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUNG	Common Stock	Sale	-$257K	-7K	-4.03%	$36.71	167K	Aug 16, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.39 to $37.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.39 to $37.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.